Tag: Nature Communications
Nine repurposed drugs show neuron protection in Sanfilippo model
A Nature Communications study pairs drug screening with machine learning against MPS IIIA.
AI minibinders bind PD-L1 but falter on other cancer targets
New screens show AI-designed minibinders hit PD-L1 but struggle on other cancer targets.